Peter J. Goss Discusses $71 Million Amgen Off-Label Marketing Settlement in Law360

Law360 quoted Peter J. Goss in its analysis of the recent $71 million settlement between Amgen and the Attorneys General of 48 states and the District of Columbia over alleged off-label marketing of two of the company’s blockbuster drugs, Enbrel and Aranesp.  Goss commented that the settlement was driven by a December 2012 settlement of […]

Peter J. Goss Quoted on “Product Liability Cases To Watch In The Second Half Of 2015”

Law360 interviewed Peter Goss for an article discussing noteworthy product liability cases that are currently pending.  Goss cited the federal multi-district litigation over the cholesterol drug Lipitor and the increased risk of diabetes allegedly associated with its use.  “Millions of Americans have diabetes, and millions of people take Lipitor, and it would potentially open the […]